State-Level Estimates of the Prevalence of Parent-Reported ADHD Diagnosis and Treatment Among U.S. Children and Adolescents, 2016 to 2019

J Atten Disord. 2022 Nov;26(13):1685-1697. doi: 10.1177/10870547221099961. Epub 2022 May 22.

Abstract

Objective: To provide state-level estimates of diagnosed ADHD and associated treatment among children in the United States in 2016 to 2019.

Method: This study used the National Survey of Children's Health to produce national and state-level estimates of lifetime diagnosis and current ADHD among all children aged 3 to 17 years (n=114,476), and national and state-level estimates of medication and behavioral treatment use among children with current ADHD.

Results: The state-level estimates of diagnosed ADHD ranged from 6.1% to 16.3%. Among children with current ADHD, state-level estimates of ADHD medication usage ranged from 37.8% to 81.4%, and state-level estimates of behavioral treatment ranged from 38.8% to 61.8%.

Conclusion: There was substantial state-level variation for indicators of ADHD diagnosis and associated treatment. These state-level results can be used by policymakers, public health practitioners, health care providers, and other stakeholders to help address the service needs of children with ADHD in their states.

Keywords: ADHD; behavior therapy; children; diagnosis; medication.

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity* / diagnosis
  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Attention Deficit Disorder with Hyperactivity* / epidemiology
  • Behavior Therapy
  • Child
  • Child Health
  • Humans
  • Parents
  • Prevalence
  • United States / epidemiology